How effective are two anti-clotting agents (heparin and bivalirudin) in the management of heart attack patients receiving Primary angioplasty (urgent procedure to restore blood flow to the heart by opening the blocked artery using small balloons and stents) treatment

Phase 1

• Conditions: ST elevation myocardial infarction; MedDRA version: 14.0Level: PTClassification code 10000891Term: Acute myocardial infarctionSystem Organ Class: 10007541 - Cardiac disorders; Therapeutic area: Diseases [C] - Cardiovascular Diseases [C14]

• Registration Number: EUCTR2011-005273-23-GB
• Lead Sponsor: iverpool Heart and Chest Hospital

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2011-12-12
• Last Update Posted: 27 July 2020

Recruitment & Eligibility

• Status: ot Recruiting
• Sex: All
• Target Recruitment: 1800

Inclusion Criteria

Patients presenting to participating centres with an ST elevation myocardial infarction event with PPCI as the proposed index reperfusion strategy
Are the trial subjects under 18? no
Number of subjects for this age range: 0
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 900
F.1.3 Elderly (>=65 years) yes
F.1.3.1 Number of subjects for this age range 900

Exclusion Criteria

•= 18 years of age
•>12 hours since onset of severe pain
•Known intolerance, hypersensitivity or contraindication to any trial
medication
•Active bleeding at presentation
•Artificial ventilation, reduced conscious level or other factors precluding
the administration of oral anti-platelet therapy
•Previous enrolment in this trial

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified